Medicare Enrolled

Dr. Hadi Estakhri, M.D.

Psychiatry · Newport Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1401 DOVE ST STE 420, Newport Beach, CA 92660
9499450927
In practice since 2012 (13 years)
NPI: 1003161522 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Estakhri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Estakhri? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Estakhri

Dr. Hadi Estakhri is a psychiatry specialist in Newport Beach, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Estakhri performed 2,671 Medicare services across 629 unique beneficiaries.

Between the years covered by Open Payments, Dr. Estakhri received a total of $16,389 from 37 pharmaceutical and/or device companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Estakhri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 3% volume in CA $16,389 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,671
Medicare services
Top 3% in CA for psychiatry
629
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~205 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
1,150 $52 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,139 $91 $280
Psychiatric services complicated by communication factor
Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient.
284 $11 $50
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
60 $144 $402
New patient office visit, complex (60-74 min) 38 $181 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,389
Total received (2018-2024)
Avg $2,341/year across 7 years
Top 4% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
699
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,389 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,047
2023
$4,120
2022
$2,784
2021
$1,799
2020
$409
2019
$2,429
2018
$801

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$700
Lundbeck LLC
$400
Alkermes, Inc.
$352
Otsuka America Pharmaceutical, Inc.
$338
IRONSHORE PHARMACEUTICALS INC.
$296
Noven Therapeutics, LLC
$249
Neurocrine Biosciences, Inc.
$233
Vanda Pharmaceuticals Inc.
$219
ABBVIE INC.
$179
Janssen Pharmaceuticals, Inc
$164
Corium, LLC
$147
IDORSIA PHARMACEUTICALS US INC
$115
Takeda Pharmaceuticals U.S.A., Inc.
$113
Indivior Inc.
$88
Teva Pharmaceuticals USA, Inc.
$85
Axsome Therapeutics, Inc.
$64
Lilly USA, LLC
$53
Almatica Pharma LLC
$51
Tris Pharma Inc
$41
Novo Nordisk Inc
$39
Bausch Health US, LLC
$33
OWP Pharmaceuticals, Inc.
$33
Supernus Pharmaceuticals, Inc.
$31
Avion Pharmaceuticals
$23
Top 3 companies account for 35.9% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,832
ITI, Inc.
$1,502
Alkermes, Inc.
$1,496
Sunovion Pharmaceuticals Inc.
$1,148
Neurocrine Biosciences, Inc.
$1,080
Janssen Pharmaceuticals, Inc
$958
Lundbeck LLC
$826
ABBVIE INC.
$774
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$700
Teva Pharmaceuticals USA, Inc.
$676
Takeda Pharmaceuticals U.S.A., Inc.
$667
Corium, LLC
$626
Vanda Pharmaceuticals Inc.
$471
Ironshore Pharmaceuticals Inc.
$406
Supernus Pharmaceuticals, Inc.
$397
Noven Therapeutics, LLC
$315
IRONSHORE PHARMACEUTICALS INC.
$296
ACADIA Pharmaceuticals Inc
$236
AbbVie Inc.
$224
IDORSIA PHARMACEUTICALS US INC
$195
JAZZ PHARMACEUTICALS INC.
$180
Axsome Therapeutics, Inc.
$178
Tris Pharma Inc
$145
Bausch Health US, LLC
$142
Allergan Inc.
$125
Avanir Pharmaceuticals, Inc.
$124
LivaNova USA, Inc.
$116
OWP Pharmaceuticals, Inc.
$101
Indivior Inc.
$88
Allergan, Inc.
$81
EISAI INC.
$61
Lilly USA, LLC
$53
Almatica Pharma LLC
$51
Novo Nordisk Inc
$39
Sumitomo Pharma America, Inc.
$30
Avion Pharmaceuticals
$23
Neos Therapeutics, LP
$22
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · Dayvigo · Dyanavel XR · FANAPT · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JARDIANCE · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · Methylphenidate Hydrochloride · NUEDEXTA · NUPLAZID · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · SUBLOCADE · SUBVENITE · SUNOSI · Subvenite · TRINTELLIX · Trintellix · UZEDY · VNS - Symmetry · VRAYLAR · Vivitrol 380 mg · WELLBUTRIN XL · Wegovy · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for psychiatry in CA.

Looking for a psychiatry specialist in Newport Beach?
Compare psychiatrists in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
730
Per 100K population
23.1
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Estakhri is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 4% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Estakhri experienced with psychotherapy and evaluation, 30 minutes?
Based on Medicare claims data, Dr. Estakhri performed 1,150 psychotherapy and evaluation, 30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Estakhri receive payments from pharmaceutical companies?
Yes. Dr. Estakhri received a total of $16,389 from 37 companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Estakhri's costs compare to other psychiatrists in Newport Beach?
Dr. Estakhri's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Estakhri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →